{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:27:59Z","timestamp":1750937279009},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T00:00:00Z","timestamp":1353456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0049845","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T23:23:59Z","timestamp":1353540239000},"page":"e49845","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Continuous Infusion of Piperacillin\/Tazobactam in Septic Critically Ill Patients\u2014A Multicenter Propensity Matched Analysis"],"prefix":"10.1371","volume":"7","author":[{"given":"Jo\u00e3o","family":"Gon\u00e7alves-Pereira","sequence":"first","affiliation":[]},{"given":"Bruno Serra","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"S\u00e9rgio","family":"Janeiro","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Estilita","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Salgueiro","sequence":"additional","affiliation":[]},{"given":"Alfredo","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"Joao","family":"Gouveia","sequence":"additional","affiliation":[]},{"given":"Carolina","family":"Paulino","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Bento","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"P\u00f3voa","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,11,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of \u2018bug and drug\u2019","volume":"2","author":"GL Drusano","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/MCC.0b013e3283021b3a","article-title":"Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?","volume":"14","author":"J Roberts","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1128\/AAC.43.10.2559","article-title":"Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing","volume":"43","author":"J Lipman","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jac\/dkm467","article-title":"Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection","volume":"61","author":"R De Jongh","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijantimicag.2009.10.008","article-title":"First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis","volume":"35","author":"JA Roberts","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5414\/CPP46157","article-title":"Cefepime in intensive care unit patients: validation of a population pharmacokinetic approach and influence of covariables","volume":"46","author":"B Georges","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/cc11405","article-title":"Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial","volume":"16","author":"I Chytra","year":"2012","journal-title":"Crit Care"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jac\/dkl478","article-title":"Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study","volume":"59","author":"JA Roberts","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/CCM.0b013e3181a0054d","article-title":"A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics","volume":"37","author":"JA Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2334-11-181","article-title":"Does prolonged beta-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials","volume":"11","author":"PD Tamma","year":"2011","journal-title":"BMC Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37: 840\u2013851; quiz 859.","DOI":"10.1097\/CCM.0b013e3181961bff"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/oxfordjournals.aje.a010011","article-title":"Invited commentary: propensity scores","volume":"150","author":"MM Joffe","year":"1999","journal-title":"Am J Epidemiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study","volume":"270","author":"GallJR Le","year":"1993","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/510590","article-title":"Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy","volume":"44","author":"TP Lodise Jr","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/cc6818","article-title":"Pharmacodynamic optimization of beta-lactams in the patient care setting","volume":"12","author":"DP Nicolau","year":"2008","journal-title":"Crit Care"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(05)70218-8","article-title":"Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials","volume":"5","author":"SK Kasiakou","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1097\/CCM.0b013e318170ba21","article-title":"Alveolar concentrations of piperacillin\/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia","volume":"36","author":"E Boselli","year":"2008","journal-title":"Crit Care Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijantimicag.2008.10.025","article-title":"Clinical cure of ventilator-associated pneumonia treated with piperacillin\/tazobactam administered by continuous or intermittent infusion","volume":"33","author":"L Lorente","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"WA Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijantimicag.2006.02.020","article-title":"Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients","volume":"28","author":"MR Rafati","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s001340000741","article-title":"Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing","volume":"27","author":"J Lipman","year":"2001","journal-title":"Intensive Care Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0002-9343(79)90242-0","article-title":"A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients","volume":"67","author":"GP Bodey","year":"1979","journal-title":"Am J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1213\/01.ANE.0000077077.54084.B0","article-title":"Cefepime versus cefpirome: the importance of creatinine clearance","volume":"97","author":"J Lipman","year":"2003","journal-title":"Anesth Analg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00003246-199001000-00010","article-title":"Effects of treatment and the metabolic response to injury on drug clearance: a prospective study with piperacillin","volume":"18","author":"LR Shikuma","year":"1990","journal-title":"Crit Care Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00134-006-0421-1","article-title":"Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients","volume":"32","author":"JM Conil","year":"2006","journal-title":"Intensive Care Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/0310057X0803600507","article-title":"Glomerular hyperfiltration and albuminuria in critically ill patients","volume":"36","author":"O Fuster-Lluch","year":"2008","journal-title":"Anaesth Intensive Care"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1186\/cc10262","article-title":"A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance","volume":"15","author":"JP Baptista","year":"2011","journal-title":"Crit Care"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2253-11-3","article-title":"Antibiotic dosing in the \u2018at risk\u2019 critically ill patient: Linking pathophysiology with pharmacokinetics\/pharmacodynamics in sepsis and trauma patients","volume":"11","author":"JA Roberts","year":"2011","journal-title":"BMC Anesthesiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2334-12-152","article-title":"DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic","volume":"12","author":"JA Roberts","year":"2012","journal-title":"BMC Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc9091","article-title":"Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock","volume":"14","author":"FS Taccone","year":"2010","journal-title":"Crit Care"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/AAC.40.1.139","article-title":"Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection","volume":"40","author":"P Bourget","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1378\/chest.10-2371","article-title":"Antibiotic dosing in multiple organ dysfunction syndrome","volume":"139","author":"M Ulldemolins","year":"2011","journal-title":"Chest"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/cc8941","article-title":"Prospective monitoring of cefepime in intensive care unit adult patients","volume":"14","author":"TM Chapuis","year":"2010","journal-title":"Crit Care"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1371\/journal.pmed.0020167","article-title":"Treating critical illness: the importance of first doing no harm","volume":"2","author":"M Singer","year":"2005","journal-title":"PLoS Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijantimicag.2010.06.008","article-title":"Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept","volume":"36","author":"JA Roberts","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2110-5820-2-35","article-title":"Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review","volume":"2","author":"FB Sime","year":"2012","journal-title":"Annals of Intensive Care"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/cc10441","article-title":"Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams","volume":"15","author":"J Goncalves-Pereira","year":"2011","journal-title":"Crit Care"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0049845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T21:40:46Z","timestamp":1562362846000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0049845"}},"subtitle":[],"editor":[{"given":"Jorge I F.","family":"Salluh","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,11,21]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0049845","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,21]]}}}